V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20191419 | 20123620 | 1.54 | 67.9 | Palliative (P) | 2019-04-07 | 2019-04-15 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101093009 |
| 20191423 | 20123621 | 1.87 | 76 | Palliative (P) | 2018-12-22 | 2018-12-24 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100628173 |
| 20191431 | 20123622 | 1.67 | 66 | Palliative (P) | null | 2020-02-29 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100576127 |
| 20191432 | 20123623 | 1.67 | 71.6 | Palliative (P) | 2019-06-12 | 2019-06-12 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100005335 |
| 20191434 | 20123624 | 1.84 | 68.25 | null | 2017-05-18 | 2017-06-01 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101251030 |
| 20191435 | 20123625 | 1.86 | 109.2 | null | 2016-03-19 | 2016-03-26 | Gemcitabine + Capecitabine | N | null | CAPECITABINE + GEMCITABINE | 100059238 |
| 20191436 | 20123626 | 1.88 | 79.3 | Curative (C) | 2018-03-30 | 2018-12-08 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100281377 |
| 20191443 | 20123627 | 1.6 | 55 | null | 2019-08-19 | 2019-12-08 | Docetaxel | 02 | null | DOCETAXEL | 101691345 |
| 20191445 | 20123628 | 1.82 | 44.8 | null | 2019-02-01 | 2019-03-05 | Cetuximab + FOLFIRI cycle1 | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101470504 |
| 20191450 | 20123629 | 1.63 | 72.8 | 03 | 2017-10-14 | 2017-10-23 | Gemcitabine + Capecitabine | 2 | N | CAPECITABINE + GEMCITABINE | 100176252 |
| 20191456 | 20123630 | 1.59 | 82 | Palliative (P) | 2020-02-09 | 2020-02-09 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CAPECITABINE + GEMCITABINE | 101489323 |
| 20191458 | 20123631 | 1.74 | 80.7 | null | 2018-03-31 | 2018-04-13 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101639663 |
| 20191460 | 20123632 | 1.69 | 96 | Palliative (P) | 2018-07-06 | 2018-07-18 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100288953 |
| 20191462 | 20123633 | 1.93 | 90.3 | Palliative (P) | 2016-11-09 | 2016-12-09 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100080384 |
| 20191463 | 20123634 | 1.76 | 73.1 | Palliative (P) | 2017-10-29 | 2017-10-29 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | CAPECITABINE + GEMCITABINE | 101446439 |
| 20191467 | 20123635 | 1.83 | 80 | Palliative (P) | 2017-10-25 | 2017-11-03 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100543125 |
| 20191468 | 20123636 | 1.67 | 81.8 | Palliative (P) | 2018-03-13 | 2018-09-09 | Gemcitabine + Capecitabine | 2 | N | CAPECITABINE + GEMCITABINE | 101301067 |
| 20191470 | 20123637 | 1.66 | 70.3 | null | 2017-03-28 | 2017-03-30 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101714155 |
| 20191473 | 20123638 | 1.67 | 66 | 02 | 2017-11-03 | 2018-01-02 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101115426 |
| 20191474 | 20123639 | 1.74 | 69.7 | Adjuvant (A) | 2016-09-13 | 2016-09-27 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101786200 |
| 20191480 | 20123640 | 1.69 | 92.8 | Palliative (P) | 2017-02-24 | 2019-02-10 | Cetuximab + FLUOROURACIL + FOLINIC ACID + IRINOTECAN | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100531756 |
| 20191484 | 20123641 | 1.7 | 67 | Palliative (P) | 2019-11-21 | 2019-11-28 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101612776 |
| 20191485 | 20123642 | 1.82 | 95 | Palliative (P) | 2017-08-27 | 2017-09-16 | Cetuximab + FOLFIRI cycle1 | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100376034 |
| 20191490 | 20123643 | 1.72 | 68 | null | 2018-05-09 | 2018-05-15 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101698328 |
| 20191491 | 20123644 | 1.61 | 64.6 | null | 2017-03-24 | 2017-03-24 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 100299575 |
| 20191493 | 20123645 | 1.7 | 83.75 | Palliative (P) | 2018-02-11 | 2018-02-20 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100187723 |
| 20191498 | 20123646 | 1.95 | 70.05 | Palliative (P) | 2019-01-31 | 2019-02-28 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100085460 |
| 20191499 | 20123647 | 1.74 | 71.8 | Palliative (P) | 2019-07-02 | 2019-07-09 | Docetaxel 75mg/m2 (21 day) | null | N | DOCETAXEL | 100203109 |
| 20191500 | 20123648 | 1.63 | 76.5 | Palliative (P) | 2019-07-08 | 2019-07-09 | Docetaxel | 02 | N | DOCETAXEL | 100383462 |
| 20191509 | 20123649 | 1.52 | 72.55 | Palliative (P) | 2018-12-10 | 2019-01-19 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100024671 |
| 20191511 | 20123650 | 1.74 | 69.1 | Palliative (P) | 2020-08-24 | 2020-12-05 | Cetuximab + FOLFIRI cycle1 | N | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100583163 |
| 20191513 | 20123651 | 1.76 | 96.4 | Palliative (P) | 2017-12-27 | 2018-03-26 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100333090 |
| 20191514 | 20123652 | 1.6 | 93.3 | Palliative (P) | 2019-01-19 | 2019-04-05 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101295384 |
| 20191515 | 20123653 | 0 | 87.4 | Palliative (P) | 2019-10-19 | 2019-12-15 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100954286 |
| 20191517 | 20123654 | 1.6 | 61.8 | null | 2017-11-24 | 2017-12-08 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CAPECITABINE + GEMCITABINE | 101130489 |
| 20191520 | 20123655 | 1.59 | 69.7 | Palliative (P) | 2019-03-13 | 2019-03-16 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101390317 |
| 20191522 | 20123656 | 1.59 | 53.8 | null | 2017-08-23 | 2017-09-14 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100974551 |
| 20191523 | 20123657 | 1.66 | 58.9 | 03 | 2018-05-29 | 2018-05-29 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100616463 |
| 20191526 | 20123658 | 1.74 | 53.25 | Palliative (P) | 2020-03-28 | 2020-03-28 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100791871 |
| 20191529 | 20123659 | 1.61 | 103 | Palliative (P) | 2019-09-03 | 2019-09-12 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101365584 |
| 20191531 | 20123660 | 1.61 | 80 | null | 2016-12-18 | 2017-06-08 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100804263 |
| 20191534 | 20123661 | 1.67 | 58 | null | 2018-03-12 | 2019-06-24 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101370093 |
| 20191535 | 20123662 | 1.67 | 70 | Palliative (P) | 2016-09-09 | 2016-09-17 | CETUXIMAB + IRINOTECAN + MDG | null | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100112217 |
| 20191536 | 20123663 | 1.59 | 95 | Palliative (P) | 2019-02-13 | 2020-01-15 | CETUXIMAB + IRINOTECAN + MDG | N | N | DOCETAXEL | 101059212 |
| 20191537 | 20123664 | 1.68 | 71.6 | null | 2017-04-28 | 2017-05-03 | Docetaxel | 02 | null | DOCETAXEL | 100115213 |
| 20191538 | 20123665 | 1.59 | 83 | Palliative (P) | 2016-07-02 | 2017-07-31 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100124190 |
| 20191540 | 20123666 | 1.7 | 66.4 | Palliative (P) | 2019-02-16 | 2019-03-04 | Docetaxel | 02 | N | DOCETAXEL | 101161047 |
| 20191542 | 20123667 | 1.67 | 51.8 | null | 2020-04-17 | 2020-04-24 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101748721 |
| 20191543 | 20123668 | 1.7 | 98.2 | Palliative (P) | null | 2020-12-13 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100444739 |
| 20191544 | 20123669 | 1.52 | 54 | Palliative (P) | 2017-03-16 | 2018-04-13 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100963666 |